相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness
Marti Farrera-Sal et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
Guillem Pascual-Pasto et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models
Marc Garcia-Moure et al.
SCIENTIFIC REPORTS (2019)
Tumor-produced hyaluronan contributes to the formation tolerogenic immunosuppressive microenvironment
Paul R. Dominguez-Gutierrez et al.
CANCER RESEARCH (2019)
Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
Jacob M. Ricca et al.
MOLECULAR THERAPY (2018)
Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus
Ahmed Abdullah Al-Zaher et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases
Richard L. Wasserman
IMMUNOTHERAPY (2017)
Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model
Esther Rincon et al.
ONCOTARGET (2017)
Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor Efficacy
Carlos Alberto Fajardo et al.
CANCER RESEARCH (2017)
The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
Naiara Martinez-Velez et al.
CLINICAL CANCER RESEARCH (2016)
Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers
Tuuli Ranki et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Insertion of exogenous epitopes in the E3-19K of oncolytic adenoviruses to enhance TAP-independent presentation and immunogenicity
A. Rodriguez-Garcia et al.
GENE THERAPY (2015)
Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
Norman Woller et al.
MOLECULAR THERAPY (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression
Alba Rodriguez-Garcia et al.
CLINICAL CANCER RESEARCH (2015)
Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity
Ines Fernandez-Ulibarri et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Tumor-Associated Hyaluronan Limits Efficacy of Monoclonal Antibody Therapy
Netai C. Singha et al.
MOLECULAR CANCER THERAPEUTICS (2015)
iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy
C. Puig-Saus et al.
GENE THERAPY (2014)
Interstitial fluid flow in cancer: implications for disease progression and treatment
Jennifer M. Munson et al.
CANCER MANAGEMENT AND RESEARCH (2014)
Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer
P. P. Provenzano et al.
BRITISH JOURNAL OF CANCER (2013)
Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
David P. Conrad et al.
CLINICAL CANCER RESEARCH (2013)
Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD
J. J. Rojas et al.
GENE THERAPY (2012)
Binding of Trastuzumab to ErbB2 Is Inhibited by a High Pericellular Density of Hyaluronan
Timea Varadi et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Failure of Translation of Human Adenovirus mRNA in Murine Cancer Cells Can be Partially Overcome by L4-100K Expression In Vitro and In Vivo
Anna-Mary Young et al.
MOLECULAR THERAPY (2012)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Prostate Cancer Increases Hyaluronan in Surrounding Nonmalignant Stroma, and This Response Is Associated with Tumor Growth and an Unfavorable Outcome
Andreas Josefsson et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Selectivity and Efficiency of Late Transgene Expression by Transcriptionally Targeted Oncolytic Adenoviruses Are Dependent on the Transgene Insertion Strategy
Christina Quirin et al.
HUMAN GENE THERAPY (2011)
Strategies to Enhance Viral Penetration of Solid Tumors
Elspeth Smith et al.
HUMAN GENE THERAPY (2011)
Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
Sonia Guedan et al.
MOLECULAR THERAPY (2010)
Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function
Richard J. Stanton et al.
BIOTECHNIQUES (2008)
Bioselection of a Gain of Function Mutation that Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency
Alena Gros et al.
CANCER RESEARCH (2008)
Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models
Shanthi Ganesh et al.
CLINICAL CANCER RESEARCH (2008)
Expression of heterologous genes in oncolytic adenoviruses using picornaviral 2A sequences that trigger ribosome skipping
Garth M. Funston et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Targeted and shielded adenovectors for cancer therapy
Susan J. Hedley et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector
TD McKee et al.
CANCER RESEARCH (2006)
Replication-dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice-acceptor site
JE Carette et al.
JOURNAL OF GENE MEDICINE (2005)
Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival
P Auvinen et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
